Status: Closed 11/04
Eligibility:

* Dogs with advanced or metastatic cancer
* At least one solid tumor accessible to biopsy
* All solid tumor types (including lymphoma) with the exception of hemangiosarcoma
* No concurrent therapies
* Prior therapies allowed, but must be discontinued at least 2 weeks prior to start of this trial
* No concurrent use of steroids or antibiotics

Trial Support:
All costs associated with the trial will be provided by the sponsor, excluding initial consult examination to determine patient eligibility